SCHEMBL4464213

SCHEMBL4464213

CC(C)(C)c1cc2c(cc1O)C1(CC2(C)C)CC(C)(C)c2cc(C(C)(C)C)c(O)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
ALOX15 P16050 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
MAPT P10636 1/20 0.50
ATP2A2 P16615 1/20 0.50
ATP2A3 Q93084 1/20 0.50
TP53 P04637 3/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 2/20 0.39
HPGD P15428 1/20 0.39
CYP2C9 P11712 2/20 0.38
TYR P14679 2/20 0.38
HTT P42858 2/20 0.38
NR1I2 O75469 1/20 0.38
MIF P14174 1/20 0.38
NFE2L2 Q16236 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29740749 1.00 ALDH1A1 (0.50) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL11160785 0.92 ALDH1A1 (0.54) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL24053470 0.91 ALOX15 (0.41) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL23633278 0.85 ALDH1A1 (0.54) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL29569404 0.84 RXRA (0.35) ALDH1A1KDM4ECYP1A2MAPTTP53
SCHEMBL196263 0.84 RXRA (0.35) ALDH1A1KDM4ECYP1A2MAPTTP53
SCHEMBL11163156 0.80 ALOX15 (0.41) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL3414363 0.79 ALDH1A1 (0.40) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL3417210 0.78 ALDH1A1 (0.41) ALDH1A1ALOX15SMN1; SMN2KDM4ECYP1A2
SCHEMBL218400 0.77 ALDH1A1 (0.37) ALDH1A1ALOX15KDM4ECYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213011-A1 7,7'-DIHALO-3,3,3',3'-TETRAMETHYL-1,1'-SPIROBIINDANE AND PREPARATION METHOD THEREOF ZHEJIANG UNIVERSITY (CN) 2022-07-07 US disclosed
US-11377457-B2 3,3,3',3'-tetramethyl-1,1'-spirobiindane-based monophosphine ligand, intermediates thereof, preparation method and use of the same ZHEJIANG UNIVERSITY (CN) 2022-07-05 US disclosed
US-20210070789-A1 3,3,3',3'-TETRAMETHYL-1,1'-SPIROBIINDANE-BASED MONOPHOSPHINE LIGAND, INTERMEDATES TEHREOF, PREPARATION METHOD AND USE OF THE SAME ZHEJIANG UNIVERSITY (CN) 2021-03-11 US disclosed
CN-108659046-B Monophosphine ligand based on tetramethyl spiroindane skeleton, intermediate thereof, preparation method and application 浙江大学 2020-04-10 CN disclosed
WO-2019213987-A1 MONOPHOSPHINE LIGAND BASED ON TETRAMETHYL SPIROBIINDANE SKELETON AND INTERMEDIATE THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF 浙江大学 (CN) 2019-11-14 WO disclosed
US-7582355-B2 Optical unit using plastic lenses FUJIFILM CORPORATION (JP) 2009-09-01 US disclosed
US-20060046065-A1 Optical unit using plastic lenses FUJI PHOTO FILM CO., LTD. 2006-03-02 US disclosed
US-6028161-A EXCELLENT TRANSPARENCY, HEAT RESISTANCE AND MECHANICAL PROPERTIES AND A LOW BIREFRINGENCE, MELT FLUIDITY AND MOLDABILITY; AN OPTICAL DISK, LENS AND AN OPTICAL FIBER MITSUI CHEMICALS, INC. (JP) 2000-02-22 US disclosed
EP-0926180-A2 A polycarbonate copolymer and applications thereof Mitsui Chemicals, Inc. (JP) 1999-06-30 EP disclosed
EP-0307951-B1 Light-sensitive resin composition FUJI PHOTO FILM CO LTD (JP) 1994-03-02 EP disclosed
US-4883739-A PHOTORESISTS FUJI PHOTO FILM CO., LTD. (JP) 1989-11-28 US disclosed
EP-0307951-A2 Light-sensitive resin composition FUJI PHOTO FILM CO., LTD. (JP) 1989-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11377457-B2 3,3,3',3'-tetramethyl-1,1'-spirobiindane-based monophosphine ligand, intermediates thereof, preparation method and use of the same PHOSPHO1, TPI1, TPR ALDH1A1 219/4885ALOX15 2430/4885SMN1; SMN2 4445/4885
US-20220213011-A1 7,7'-DIHALO-3,3,3',3'-TETRAMETHYL-1,1'-SPIROBIINDANE AND PREPARATION METHOD THEREOF TALDO1, REN, PKD1 ALDH1A1 123/4885ALOX15 994/4885SMN1; SMN2 4121/4885
US-20210070789-A1 3,3,3',3'-TETRAMETHYL-1,1'-SPIROBIINDANE-BASED MONOPHOSPHINE LIGAND, INTERMEDATES TEHREOF, PREPARATION METHOD AND USE OF THE SAME PHOSPHO1, TPI1, TALDO1 ALDH1A1 477/4885ALOX15 3772/4885SMN1; SMN2 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.